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a  b  s  t  r  a  c  t
Although  copper  (Cu)  is recognized  as  an  essential  trace  element,  uncertainties  remain  regarding  Cu  ref-
erence values  for humans,  as  illustrated  by  discrepancies  between  recommendations  issued  by different
national  authorities.  This  review  examines  human  studies  published  since  1990  on  relationships  between
Cu  intake,  Cu  balance,  biomarkers  of  Cu status,  and  health.  It points  out several  gaps  and unresolved  issues
which  make  it difﬁcult  to  assess  Cu  requirements.  Results  from  balance  studies  suggest  that  daily  intakes
below  0.8  mg/day  lead  to  net  Cu  losses,  while  net  gains  are  consistently  observed  above  2.4 mg/day.  How-
ever,  because  of  an  incomplete  collection  of  losses  in  all  studies,  a precise  estimation  of Cu  requirements
cannot  be derived  from  available  data.  Data  regarding  the  relationship  between  Cu  intake  and  potential
biomarkers  are  either  too  preliminary  or  inconclusive  because  of low  speciﬁcity  or low sensitivity  to
change  in  dietary  Cu over  a wide  range  of  intakes.  Results  from  observation  and  intervention  studies  do
not support  a link between  Cu  and  a  risk  of cardiovascular  disease,  cognitive  decline,  arthritis  or  can-
cer  for  intakes  ranging  from  0.6  to 3 mg/day,  and  limited  evidence  exists  for impaired  immune  function
in  healthy  subjects  with  a very  low  (0.38 mg/day)  Cu  intake.  However,  data  from  observation  studies
should  be regarded  with caution  because  of uncertainties  regarding  Cu  concentration  in various  foods
and  water.  Further  studies  that  accurately  evaluate  Cu  exposure  based  on  reliable  biomarkers  of  Cu status
are needed.
©  2016  The  Authors.  Published  by  Elsevier  GmbH.  This  is an  open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Contribution of the main food groups to Cu intake in the French population
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. Introduction
Copper (Cu) is an essential trace element in both humans and
nimals. Needed only in trace amounts, the human body contains
pproximately 100 mg  Cu. As a transition metal, it is a cofactor
f many redox enzymes, Ceruloplasmin being the most abundant
u-dependent ferroxidase enzyme with a Cu-dependent oxida-
ion activity. Beyond its role in iron metabolism, the need for
u also derives from its involvement in a myriad of biological
rocesses, including antioxidant defense, neuropeptide synthesis
nd immune function [1,2]. As a consequence, the wide range of
linical features resulting from perturbations in the activities of
uproenzymes [3] means that although severe Cu deﬁciency is
elatively straightforward to diagnose, identifying marginal deﬁ-
iency is somewhat problematic. Dietary Cu deﬁciency can result
n adverse consequences throughout the life span. In utero, Cu deﬁ-
iency may  result in impaired development of the cardiovascular
ystem, bone malformation and ongoing neurologic and immuno-
ogic abnormalities into infancy and beyond [4,5]. In adulthood,
rolonged marginal Cu deﬁciency has been associated with alter-
tions in cholesterol metabolism [6,7].
Though an essential micronutrient for man, Cu is toxic at high
evels. An overload of this metal easily leads to Fenton-type redox
eactions, resulting in oxidative cell damage and cell death. How-
ver, Cu toxicity as a result of dietary excess is generally not
onsidered a widespread health concern, probably as a result of the
omeostatic mechanisms controlling Cu absorption and excretion
8].
Dietary reference values for Cu were established for the French
opulation more than a decade ago. Because of the lack of data on
u metabolism, dietary reference values have been based on data
rom dietary surveys and balance studies.
The French population reference intakes (ANC—apports nutri-
ionnels conseillés) for Cu are presented in Table 1, along with those
stablished in other countries.
Discrepancies between current recommendations highlight the
ifﬁculties in establishing a requirement for dietary Cu. The aim of
his literature review is to present the current knowledge regard-
ng Cu intake and metabolism, biomarkers of Cu intake, and the
elationship between dietary Cu and health.
. Copper metabolism and balance
A description of the mechanism involved in Cu transport across
he GI tract is beyond the scope of this review and readers interested
n this topic are invited to refer to recent reviews [9–11].
Cu absorption occurs mainly in the proximal part of the small
ntestine, where it is transported into the liver via the portal vein. It
s complicated to measure true fractional absorption of Cu because
f important fecal Cu excretion and the existence of only two  stable
sotopes, 63Cu (69.2% natural abundance) and 65Cu (30.8% natu-
al abundance), which makes it impossible to use a dual labelingFig. 2. Whole-body Cu pools and ﬂuxes.
technique to correct apparent absorption for biliary and gastroin-
testinal re-excretion. In most studies, fractional Cu absorption has
been measured using extrinsic meal labeling with 65Cu and fecal
Cu monitoring for several days [12–22]. Recently, the addition of
the non-absorbable rare earth element Holmium to 65Cu-labeled
meal has been used to accurately quantify the amount of absorbed
Cu re-excreted in fecal matter [13,14]. Using this approach, it has
been concluded that true fractional absorption of Cu was close to
50%, and remained constant for Cu intake ranging from 0.7 mg/day
to 6.0 mg/day. This estimation has recently been conﬁrmed by the
analysis of fecal Cu excretion and plasma Cu appearance data after
the oral or intravenous administration of 65Cu, using a simple com-
partmental model [12].
Several parameters affect the absorption rate of dietary Cu,
including age, gender, food type, amount of dietary Cu and oral con-
traceptives. These parameters can cause the absorption rate to vary
M. Bost et al. / Journal of Trace Elements in Medicine and Biology 35 (2016) 107–115 109
Table  1
Population reference Cu intake (mg/day) in different countries.
0–6 months 6–12 months 1–3 years 4–6 years 7–10 years 11–20 years 20–50 years >50 years Pregnancy Breastfeeding
France
(2001)
0.4 0.6 0.75 1 1.2 1.5 2 (m) 1.5 2 2
1.5 (w)
USA
(2001)
0.2 0.22 0.34 1 1–1.3 (m)  1.3–1.5 (m)  1.7 (m) 1.7 (m) 1.2–1.3 1.4–1.5
1.1 (w)  1.1 (w) 1.2 (w) 1.2 (w)
Australia
(2004)
0.2  0.22 0.7 1 1–1.3 (m)  1.3–1.5 (m)  1.7 (m) 1.7 (m) 1.2–1.3 1.4–1.5
1.1 (w)  1.1 (w) 1.2 (w) 1.2 (w)
Nordic countries (2010) – 0.3 0.3–0.4 0.4 0.5 0.7–0.9 0.9 0.9 1 1.3
UK  (1991) 0.3 0.3 0.4 0.6 0.7 0.8–1 1.2 1.2 1.2 1.5
USA (2001): Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, Cu, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium and zinc.
Institute of Medicine, National Academy Press, Washington DC.
Australia (2004): Nutrient reference values for Australia and New Zealand. Melbourne, Ministry of health, Government of Australia.
N ic Cou
U Kingdo
A
b
t
s
o
t
f
c
u
f
s
a
6
a
b
w
t
t
t
r
t
t
t
ﬂ
t
s
i
m
t
l
u
n
t
c
0
[
(
C
b
e
p
e
t
o
e
t
lordic countries (2010): Nordic Nutrition recommendation 2012, 5th edition, Nord
K  (1991): Dietary reference values for food, energy and nutrients for the United 
spects of Food Policy, HSMO.
etween 12 and 71% [11]. The effect of age and gender on Cu absorp-
ion in adults has been reported in only one study [23]. Because this
tudy relies on whole-body counting after the oral administration
f the radioisotope 67Cu to estimate dietary Cu absorption, the frac-
ional absorption values cannot be compared to later estimations
rom Harvey et al. However, within this study, Cu absorption was
onsistently found to be 10% higher in women than men, and was
naffected by hormone use in women. According to this study, the
ractional absorption of Cu was similar in young adults and elderly
ubjects. In contrast, limited evidence suggests that the intestinal
bsorption of Cu is higher in infants than adults. By monitoring fecal
5Cu elimination after an oral dose, Olivares et al. have reported an
pparent fractional absorption of Cu close to 80% in fully or partially
reast-fed infants aged 13 months [24]. Because this estimation
as not corrected for intestinal Cu re-excretion, it can be assumed
hat Cu uptake from breast milk is almost total in infants.
Following intestinal absorption, 75% of portal Cu is taken up by
he liver [12] and the remainder ﬂows into the peripheral circula-
ion, mainly bound to albumin. In the liver, 20% of the Cu taken up is
e-excreted back into the gastrointestinal tract and 80% is exported
o the periphery bound to ceruloplasmin [12]. Based on Cu concen-
ration in the different gastrointestinal ﬂuids, it has been estimated
hat approximately 2.5 mg  of Cu are excreted daily in the biliary
ow, and that an equivalent amount is excreted through other gas-
rointestinal secretions, including saliva, gastric juice, pancreatic
ecretion and intestinal ﬂuid secretion [25]. Because balance stud-
es indicate that daily fecal losses of Cu are of the same order of
agnitude as dietary Cu intake [8,13,19,20], it can be concluded
hat most of the endogenous Cu secreted into the gastrointestinal
umen is reabsorbed across the intestinal epithelium. Moreover,
sing Holmium to distinguish unabsorbed dietary Cu from endoge-
ous Cu secretion in the gastrointestinal tract, it has been shown
hat the gastrointestinal secretion of Cu plays a major role in the
ontrol of Cu homeostasis, with endogenous losses increasing from
.45 to 2.46 mg/day for Cu intake increasing from 0.7 to 6 mg/day
13].
Compared to fecal excretion, urinary Cu excretion is low
10–25 g/day) [8,26,27]. The effect of dietary Cu level on urinary
u excretion is inconsistent, with some studies reporting a small
ut signiﬁcant positive relationship [8,27] and others showing no
ffect [26]. While tubular Cu re-absorption involving the ATP7A
rotein has been reported [28], there is no evidence that urinary
xcretion plays a role in the control of Cu homeostasis in response
o changes in Cu intake.
Little is known regarding the respective importance of all the
ther routes of Cu excretion. While an early report from Jacob
t al. suggests that surface losses of Cu in adult men  were close
o 300 g/day [29], a more careful estimation from the same team
ater concluded that sweat and integumentary losses averagedncil of Ministers, Copenhagen.
m. Report of the Panel on Dietary Reference values of the Committee on Medical
42 g/day [30]. Small amounts of Cu have also been reported to be
lost in normal menstrual ﬂow in women, but there is no evidence
that women’s Cu status could be compromised by menstruation.
Information regarding Cu absorption, losses and organ pools are
summarized in Fig. 2.
The results of balance studies have been used to set nutritional
requirements in adults for several minerals, including calcium,
magnesium and zinc. Four balance studies with a different level of
dietary Cu have been published since 1990 [8,13,16,20]. Because
balance calculation requires a thorough assessment of nutrient
losses, and because none of these four balance studies meet this cri-
terion, they must be considered likely to be biased, although dietary
intake was  usually carefully controlled. Fecal, urinary, sweat and
integumentary losses were only measured in some subjects of one
study [16]. In this study, however, sweat and integumentary losses
were not taken into account in the ﬁnal balance calculation. Urinary
and fecal losses were taken into account in two studies [8,31] while
only fecal losses were considered in the remaining study [13]. At
Cu intakes above 2.4 mg/day, Cu balance was  consistently reported
to be positive [8,13,20] and Cu balance values were always nega-
tive for Cu intakes below 0.8 mg/day [13,20]. The minimal amount
of dietary Cu required to achieve a null balance lies somewhere
between 0.8 and 2.4 mg/day, but the quality of the studies—and
more speciﬁcally the fact that urinary and/or surface losses were
not measured—preclude the precise estimation of Cu requirement.
3. Dietary sources and copper intake
Cu content in foodstuff varies according to local conditions. Soil
Cu concentration, slurry/manure spreading, use of Cu compounds
as bactericides or fungicides on many crops and Cu emissions from
smelting and casting industries may  affect the Cu content in cereals,
fruit and vegetables and, to a lesser extent, meat and animal prod-
ucts [32–35]. Moreover, the Cu concentration in drinking water
may also vary depending on groundwater Table composition and
household plumbing systems. Soft acidic water causes corrosion in
Cu pipes and increases tap water Cu concentration. For instance,
tap water Cu concentration has been shown to vary largely in
dwellings, with 0.02–3.5 mg/L in Berlin [36] and 0.1–5 mg/L in Upp-
sala and Malmö  [37]. Altogether, these variations represent serious
hindrances in the assessment of Cu intake both at individual and
population levels, and Cu content in food composition databases
must be considered with caution. However, despite those varia-
tions, food groups such as offal and nuts, and to a lesser extent
cereals and fruit, can be regarded as good sources of Cu, while milk
and dairy products contain low amounts (Table 2).
The Cu intake of representative samples of healthy popu-
lations have been assessed in several national dietary surveys.
In France, the second National Individual Survey on Food
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Table 2
Cu content of selected foods.
Foods Cu (mg/kg)
• Milk and dairy products
Milk, plain 0.1–0.88
Fresh cheese 0.03
Processed cheese 0.025
•  Meat and offal
Liver, beef 157
Kidney, beef 2.1–4.3
Muscle meat, beef 0.1–1.8
Muscle meat, pork 0.1–9.1
•  Cereal products
Maize products 0.6–16.6
Wheat bread 2.9
Whole grain wheat bread 3.4
Whole grain pasta 0.08–0.52
•  Vegetables
Potato 0.48–16.0
Carrot 0.37–0.62
Broccoli 0.68–0.87
Peas 1.9–2.4
Lettuce 0.1–2.9
Tomato 0.1–3.4
Cabbage 0.1–7.7
•  Seafood
Oysters 0.3–16.0
Tuna 0.1–1.2
Salmon 0.5–0.8
Shrimp 2.0–2.9
Flounder 0.1–2.5
•  Fruits
Apples 0.1–2.3
Bananas 0.7–3.0
Oranges 0.8–0.9
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Table 3
Daily Cu intake in the French population, by gender and age group.
Age (years) Male Female
3–10 1.0 ± 0.5 0.9 ± 0.3
11–14 1.2 ± 0.5 1.0 ± 0.3
15–17  1.2 ± 0.5 1.0 ± 0.3
18–34  1.5 ± 0.7 1.1 ± 0.4
35–54  1.6 ± 0.7 1.4 ± 0.6
Little information is available regarding Cu intake and adequacy
T
M
Donsumption (INCA2) includes data on dietary Cu intake, gathered
ver seven days from a representative sample of the metropoli-
an population, consisting of 2624 adults aged 18–79 years old
nd 1455 children aged 3–17 years old [38]. After excluding
ubjects with incomplete dietary records and under- or over-
eporters, dietary Cu intake was calculated for 1863 adults and
382 children aged 3–79 years old (Table 3). In adults, daily
ntake (mean ± SE) was signiﬁcantly higher in men  than women
1.53 ± 0.03 vs 1.30 ± 0.02, respectively). In both sexes, Cu intake
as lower in subjects aged 18–35 years old than in subjects
ver 35 years old, in accordance with a lower consumption of
ruit, vegetables, nuts and offal in young French adults [38]. In
hildren, daily Cu intake (mean ± SE) was 1.06 (±0.02) and 0.94
±0.01) in boys and girls, and increased with age. Intakes of Cu
n the 95th percentile are 2.4 g/day in men, 2.1 g/day in women
nd 1.6/day in children. Similar levels have been reported in
able 4
ean Cu intake in adults and the elderly in different European countries according to rep
Country Study—years Survey method
Adults (19–64 years)
FI  FINDIET 2007 adj 48H DR 
IRL  SLAN 2007 FFQ 
IT  INN-CA 1994-1996 7 day record 
UK  Health Survey for England 2000-2001 7 day record 
Elderly  (>64 years)
FI FINDIET 2007 adj 48H DR 
IRL  SLAN 2007 FFQ 
ata from Ref. [39].55–79  1.6 ± 0.9 1.4 ± 0.7
Data are from the INCA2 study [38].
other European countries for adults and the elderly (Table 4),
according to two recent reviews of representative national dietary
surveys and total diet studies [35,39] and in the US adult
population (1.5 ± 0.02 and 1.2 ± 0.02 for dietary Cu in adults over
20 years old) [40].
Food products are seldom fortiﬁed with Cu in the European
Union. The main contributors to Cu intake in the French popula-
tion are bread and cereal products (≈25–30% of dietary Cu), meat
and offal (15–20%) and legumes and vegetables (≈15%), while dairy
products, water and beverages provide less than 10% of dietary Cu
(Fig. 1) [38]. The respective contributions of these food groups to
total intake were similar in adults and children (3–17 years old)
and close to those reported in other European countries [35]. Few
data are available regarding the contribution of dietary supple-
ments to daily Cu intake in the European Union [41]. In France,
Cu intake from food supplements is very low in adults and children
and does not contribute to excessive intakes (ANSES data, working
paper). In contrast, dietary supplements signiﬁcantly contribute to
daily Cu intake in the US population. In adults, results from the
NHANES 2003–2006 survey indicate that male dietary supplement
users obtain 50% of their daily Cu intake from supplements and
females, more than 60% [42]. For both men  and women, the use of
dietary supplements resulted in a small but signiﬁcant reduction
in the prevalence of Cu inadequacy. However, with less than 10% of
adults having an intake below the estimated average requirements,
Cu inadequacy is far from being a public health issue in the US pop-
ulation, and the prevalence of inadequate intake is already lower in
supplement users than non-users when considering only Cu from
food. Dietary supplements are thus of little interest for Cu nutrition.
On the contrary, the use of dietary supplements was  associated with
a large increase in the prevalence of two- to eight-year-old children
with a total intake above the upper limit (7.7 vs 39% for non-users
and users respectively) [43]. Although little information is available
regarding the long term effects of high Cu intake in children, these
results suggest that the risk-beneﬁt ratio of dietary supplement
usage inclines toward risk as far as Cu nutrition is concerned.in populations with speciﬁc diets such as vegetarians, vegans or
those practicing macrobiotics. An analysis of duplicated meals has
shown that the Cu density of a vegan diet was more than twice that
resentative national dietary surveys.
 Men  Women
N Mean ± SD N Mean ± SD
730 1.6 ± 0.7 846 1.3 ± 0.5
662 1.5 ± 0.8 717 1.2 ± 0.7
660 1.6 ± 0.7 801 1.3 ± 0.5
219 1.4 ± 0.7 210 1.0 ± 0.4
229 1.4 ± 0.7 234 1.2 ± 0.5
580 1.4 ± 0.9 742 1.3 ± 0.7
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f an omnivorous diet (0.7 ± 0.29 vs 2.0 ± 0.34 mg/1000 kcal for the
egan and omnivorous diet respectively) [44]. In the same way,
aily Cu intake was 27% higher in vegetarians than in omnivorous
dolescent females [45]. The higher Cu content of a plant-based diet
as been consistently shown to compensate for the slightly reduced
ioavailability of Cu resulting from the presence of phytates and
bers, suggesting that diets low in or devoid of animal products
rovide an adequate amount of Cu [17,21,46].
. Biomarkers of copper exposure
The assessment of dietary adequacy of Cu is constrained by the
bsence of recognized biomarkers of Cu status. Despite the widely
eld view that there is a lack of sensitive and speciﬁc biomark-
rs of Cu status, several putative indexes—including plasma Cu,
eruloplasmin and Cu/Zn superoxide dismutase (Cu/Zn SOD)—are
outinely assayed in human studies. However, it has been pointed
hat a minimum of four weeks is needed to observe a variation in
hese biomarkers. This suggests that Cu metabolism adapts only
lowly to changes in dietary Cu intake [47]. Regardless of the possi-
le futility of these analyses [3,48], their widespread use continues
ainly due to the absence of anything better.
.1. Plasma and serum Cu
We  have identiﬁed in our review eight recent controlled trials
eporting the effect of dietary Cu intake on plasma or serum Cu
Table 5).
In one of these trials, judged as at high risk of bias, a
mall but signiﬁcant decrease in plasma Cu was observed in
oung healthy men  at the end of a Cu depletion period (dietary
u = 0.38 mg/day), compared to the preceding equilibration period
dietary Cu = 0.66 mg/day) or the subsequent repletion period
dietary Cu = 2.49 mg/day) [27].
In the other trials [13,16,26,49–51], the range of dietary Cu
ntake was 0.57–6.9 mg/day. In none of these studies did the
uthors report any difference in plasma Cu between the different
ietary Cu periods. Therefore, it seems that plasma Cu does not vary
or daily intakes between 0.57 mg  and the upper level. A very low
u intake (0.38 mg/day) may  result in a decreased plasma Cu but
his remains questionable as such a low intake was imposed in only
ne trial.
In a review on the methods for assessing Cu status, including
tudies among unhealthy populations, serum Cu appeared to reﬂect
hanges in Cu status in both Cu-depleted and Cu-replete individu-
ls, with smaller changes in Cu-replete individuals [47].
Plasma Cu concentrations are consistently reported to be lower
han serum values, which possibly contributed to a lack of response
ith the biomarker in Cu-replete individuals.
.2. Ceruloplasmin (Cp)
It is well-accepted that the responsiveness and concentration of
p can be affected by a range of non-dietary factors. Concentrations
end to increase with age and are generally higher in females than
ales throughout the life span. The latter is exacerbated in pre-
enopausal women as a result of estrogen-dependent Cp synthesis
nd secretion by the liver, and oral contraceptive use [52]. Cp is also
n acute-phase protein regulated by inﬂammatory hormones and,
onsequently, levels are raised by chronic inﬂammatory conditions,
uch as rheumatoid arthritis. Therefore, Cp concentrations should
e viewed with extreme caution. As for plasma Cu, plasma Cp and
p activity signiﬁcantly declined when dietary Cu intake shifted
rom marginal (0.66 mg/day for 24 days) to low (0.38 mg/day for
2 days) in one controlled trial involving healthy male subjectsdicine and Biology 35 (2016) 107–115 111
[27,53]. However, Cp concentration and activity did not increase
after a repletion period providing 2.49 mg  Cu/day for 24 days.
In the other trials, the range of dietary Cu intake was
0.57–6.9 mg/day. No effect of dietary Cu on plasma Cp was reported
[13,16,49–51,54–58].
The Cp values are consistent with the serum Cu levels. How-
ever, in this case, supplementation of healthy, replete individuals
showed a signiﬁcant increase in serum Cu concentration.
In a review on the methods of assessing Cu status, also includ-
ing studies among unhealthy populations, Harvey identiﬁed two
studies suggesting that Cp total protein may  be affected by Cu sup-
plementation, thus reﬂecting Cu exposure. However, these results
were only observed in unhealthy, highly depleted individuals [47].
4.3. Cu-enzymes
4.3.1. Erythrocyte superoxide dismutase (SOD)
The effect of dietary Cu on the activity of Cu/Zn erythrocyte SOD
has been assessed in ﬁve controlled trials or balance studies. None
reported any change in erythrocyte SOD in response to dietary Cu
within a range of 0.38 mg  Cu/day to 6 mg  Cu/day [13,27,50,55,56].
We  can conclude, in agreement with the conclusions of Harvey
et al. [47], that erythrocyte SOD is not a suitable marker of Cu status.
4.3.2. Diamine oxidase (DAO)
Serum DAO was  increased (compared to a placebo) after 3 mg
Cu supplementation for six weeks in two  RCTs, each with 24 partic-
ipants [55,59]. However, the studies were both considered at high
risk of bias due to an incomplete report of outcomes: in the study of
Kehoe et al. [55], results were reported for 19, 14, 20 and 17 subjects
respectively (out of 24) in the case of SOD, platelet cytochrome c
oxidase, ceruloplasmin oxidase and serum diamine oxidase. In the
study of O’Connor, the effects of Cu supplementation as CuSO4 on
DNA damage and liver function enzymes were reported for 17 and
21 subjects respectively.
We can conclude that DAO is not a suitable marker of Cu status
as reported by Harvey et al. [47].
4.3.3. Skin lysyl oxidase (SLO)
We identiﬁed only one CT carried out in 12 men [53] which
addressed the effect of Cu intake on skin lysyl oxidase activity. SLO
activity decreased when switching from a diet providing 0.66 mg
Cu/day to a diet providing 0.38 mg  Cu/day, and increased after a
repletion period (2.48 mg  Cu/day). However, based on this sole
study it is not possible to conclude that SLO can serve as a useful
indicator of Cu status.
4.3.4. Cu in hair
Compared to serum, Cu content of scalp hair is 10–100 time
higher and much more variable, with values ranging from 7 to
95 g/g [60,61]. Very few studies have investigated the relation-
ship between Cu intake and Cu content in hair. In one long term
study in healthy young men  fed controlled diet, Cu content in scalp
hair increased from 9.2 ± 3.1 to 21.1 ± 5.9 g/g when intake shifted
from 1.6 to 7.8 mg/day. In contrast, no correlation was  observed
between Cu content in scalp hair and Cu intake assessed with three
24 h recall in a cohort of 70 menstruating women [62]. Beyond
Cu intake, factors affecting the Cu content of scalp hair are still
largely unknown and may  include sex, use of hormonal contra-
ception, cancer and other pathological situations associated with
change in Cu distribution between plasma and tissues as well as
environmental pollution [63]. Hair matrice presents advantages,
with easy collection and conservation, with retrospective charac-
teristics in addition. However, these advantages are still hindered
by the problems of external contamination, the analytical difﬁcul-
ties of this matrice for metal determination with the lack of internal
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Table 5
Plasma or serum Cu in healthy subjects with different levels of Cu intake.
Study Population Cu intake per period (mg/day) Plasma or serum Cu (mol L−1)
Turnlund et al. [27] Healthy young men
(26 ± 4 years)
Equilibration: 0.66 Plasma Cu: 13.8 ± 0.3
Depletion: 0.38 Plasma Cu: 12.6 ± 0.3
Repletion:2.49 Plasma Cu: 13.6 ± 0.3
Milne  et al. [16] Men  (18–36 years) Equilibration: 1.22–1.57 Plasma Cu: 12.9 ± 1.1
Depletion: 0.73–0.99 Plasma Cu: 11.8 ± 1.9
Repletion: 4.34–6.42 Plasma Cu: 12.2 ± 2.0
Milne  et al. [51] Postmenopausal
women (63.1 ± 8.8
years)
Equilibration: 1.37 Plasma Cu: 17.3 ± 2.2
Depletion: 0.57 Plasma Cu: 18.1 ± 2.4
Repletion: 2.57 Plasma Cu: 17.0 ± 3.1
Baker et al. [49] Young adults (20–50
years)
Medium: 1.6 Serum Cu: 14.4 ± 2.3
Low: 0.7 Serum Cu: 14.0 ± 1.8
High: 6.0 Serum Cu: 15.2 ± 2.0
Harvey et al. [13] Men  (20–59 years) Medium: 1.6 Serum Cu: 15.9 ± 1.7
Low: 0.7 Serum Cu: 14.4 ± 2.1
High: 6.0 Serum Cu: 15.5 ± 2.2
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177
nd external quality controls. For all these reasons, hair copper is
ot regarded as a suitable marker of Cu status.
All the biomarkers identiﬁed in our review show very little or
o variation to Cu exposure in the dietary intake range. More infor-
ative biomarkers are needed to assess Cu status in the general
opulation. Currently, other biomarkers—such as exchangeable Cu
64]—are used in pathological conditions (Wilson Disease), and
hould be explored in further studies.
. Dietary copper and health
There are few reports of Cu excess or deﬁciency in the general
opulation except for formerly obese patients after gastric bypass
urgery, in whom Cu deﬁciency has been reported in 8 to 18.8%
65,66].
However, we have identiﬁed several studies addressing the rela-
ionship between dietary Cu and health issues for intakes in the
utritional range.
.1. Cardiovascular risk
.1.1. Cardiovascular disease
High serum Cu has been reported as an independent risk fac-
or for cardiovascular disease in both case-control [67] and large
rospective population studies [68,69]. The mechanisms under-
ying these relationships are mainly unclear. A synergistic effect
etween the pro-oxidation of Cu and low status of selenium (an
ntioxidant, leading to atherogenesis via an imbalance of defense
ystems against free radicals, has been suggested) [69].
In a cohort study, in 1,054 subjects aged 65 years old and over
mean age 76.6 ± 7.4 years old, 49% females) [70], dietary Cu intake
as not predictive of cardiovascular mortality over 14 years.
.1.2. Lipoproteins
A  cross-sectional study at high risk of bias by Bo et al. [71] car-
ied out on 1197 apparently healthy subjects (no use of prescription
edicine and without diabetes, cardiovascular disease or dyslipi-
emia) of both sexes observed a negative relationship between
ietary or serum Cu and total and LDL-cholesterol, suggesting that
 high Cu intake and status is associated with a better metabolic
roﬁle. A second cross-sectional study with 189 participants (with-
ut diabetes, cardiovascular disease or hypertension) considered at
igh risk of bias showed that serum Cu was positively associated
ith cholesterol HDL [72].
In the RCT by Davis et al. [50], for which risk of bias was unclear,
otal and LDL cholesterol did not differ between the low (0.59 mgu: 14.2 ± 12.6 mol/day
ls of drinking water Cu: 0 (Q1) to
0.9 (Q4) mol/day
No relationship between total
(dietary + drinking water) Cu intake
and serum Cu
Cu/day) and adequate Cu (2.59 mg Cu/day) periods (6 weeks each).
In the RCT of Medeiros et al. [73] considered at moderate risk of
bias, supplementation with 2 mg  Cu/day for 6 weeks triggered an
increase in total serum LDL cholesterol at 4 weeks while VLDL
cholesterol declined (in comparison with the placebo group). The
percentage of cholesterol as LDL increased at 6 weeks of sup-
plementation compared to the initial baseline value, while the
percentage of cholesterol as VLDL decreased compared to the base-
line value in the supplemented group.
Therefore, limited results from cross-sectional studies tend to
suggest that dietary Cu is associated with a better lipoprotein pro-
ﬁle. This observation is not fully supported by the results of RCTs,
but the short duration of these studies may  have precluded the
occurrence of an effect.
5.1.3. Cardiac arrhythmia
Limited evidence from RCTs also suggests that marginal intake
of Cu may  lead to cardiac arrhythmia.
In one trial, a signiﬁcant increase in the number of ventricular
premature discharges (VPDs) was observed in three women  out of
13 after 3 to 12 weeks on a low Cu diet (0.57 mg/day for 105 days)
[51].
In another study, three women  out of 12 on a low Cu diet
(1 mg/day during a 90-day controlled period) exhibited abnormal
electrocardiographic recording (premature ventricular discharge)
requiring Cu supplementation before the end of the study. How-
ever, because two  of these women  still exhibited an increased
number of abnormal ventricular discharges after Cu supplemen-
tation, no clear conclusion can be drawn regarding the relationship
between dietary Cu and cardiac arrhythmia [56].
5.2. Cognitive decline
The hypothesis that Cu intake might be linked to cognitive
decline is based on the long recognized age-related accumulation
of metal-transporting proteins and compounds in key sites of the
attentional circuits [74].
Lam et al. [75] found an inverse association between serum
Cu concentrations and cognitive performance in a large cohort of
elderly healthy women. Long-term and short-term recall scores
were signiﬁcantly lower in women with serum Cu over 2.15 mg/L
than women with serum Cu below 0.9 mg/L. This relationship was
not observed in men.
More recently, Salustri et al. [76] have reported that MMSE
scores were correlated with serum levels of free Cu, but not
of bound Cu, in healthy women. They also revealed an inverse
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orrelation between free Cu and an attention-related neuropsycho-
ogical test, the digit span (verbal and spatial short-term memory
est; attention), both in its forward and backward forms. These
bservations have prompted some authors to suggest that Cu
ccumulation, resulting from drinking water piped through Cu
lumbing, may  promote mental decline [76,77].
However, this hypothesis has been challenged by Klevay [78],
ho suggests that free serum Cu may  increase even when total
ody Cu decreases, and questions the relevance of free serum Cu
s a marker of Cu exposure. This controversy points out the need
or studies evaluating the direct relationship between Cu intake
nd cognition. Our literature review has identiﬁed only one study
ddressing this point.
A cohort study of 3718 males and females by Morris et al. [79]
dentiﬁed a potentially adverse effect of Cu-containing supple-
ents on cognitive functions in subjects with high saturated and
rans fatty acid intake, but not in subjects with a diet low in satu-
ated and trans fatty acids. Among such individuals, an average Cu
ntake of 2.75 mg/day resulted in a rate of mental decline almost
0% higher than that of individuals whose average Cu intake was
.88 mg/day. However, because factors other than Cu intake are
nvolved, this cohort study does not enable clear conclusions to be
rawn regarding the inﬂuence of Cu intake on cognitive decline.
.3. Cancers
Two cohort studies examined the link between Cu intake and
ung cancer and lymphoma.
In a large cohort study (482,875 subjects), Mahabir et al. [80]
howed no relationship between total Cu intake and lung cancer
isk. In the Iowa Women’s Health Study, Thompson et al. [81] did
ot identify any link between total or dietary Cu and the risk of
on-Hodgkin’s lymphoma, diffuse large B-cell lymphoma or fol-
icular lymphoma in a cohort of 35,159 women. For other types
f cancer, no cohort studies have assessed Cu intake. In a third
ohort study in 1,054 subjects aged 65 years old and over (mean
ge 76.6 ± 7.4 years old, 49% females) [70], dietary Cu intake was
ot predictive of cancer mortality over 14 years.
The link between Cu intake and breast cancer has not been evi-
enced by the cross-sectional and case-control studies identiﬁed in
ur review. The case-control study [82] did not show any relation-
hip in 522 women (261 cases and 261 controls) aged between 25
nd 65 years old. In the cross-sectional study [83], pre-menopausal
omen with breast cancer (n = 23) had signiﬁcantly higher plasma
u levels than the pre-menopausal controls (n = 48). However, lev-
ls of Cu intake were similar in both groups.
For other cancers, our review did not identify any relevant stud-
es assessing Cu intake.
Thus, according to our review, no conclusion can be drawn
egarding Cu intake and cancers.
.4. Arthritis
One cohort study carried out in 29,368 female subjects (mean
ge 61.4 years old) [84] found no link between total (diet and sup-
lements) or dietary Cu intake and risk of rheumatoid arthritis.
here was a weak but signiﬁcant inverse relationship between the
se of Cu supplements and the risk of rheumatoid arthritis, which
id not persist after further adjustment for confounders (age and
nergy intake, other risk factors).
Thus, no conclusion can be drawn regarding Cu intake and
heumatoid arthritis.dicine and Biology 35 (2016) 107–115 113
5.5. Copper and immune function
It has been suggested that Cu inﬂuences both humoral and
cellular factors of the immune system. Cu-deﬁcient animals have
a lighter thymus and enlarged spleen compared with controls.
Animals with severe Cu deﬁciency have reduced populations of
neutrophils and T cells, impaired proliferation of T lymphocytes
in response to mitogens and decreased activity of phagocytes,
B-lymphocytes and natural killer cells. Antibody production by
splenocyte T cells is reduced. In humans, the relationship between
Cu intake and immune function is less well documented.
Recently, there have been several reports of Cu deﬁciency in for-
merly obese patients following gastric bypass surgery [65,66]. In
these patients, features of Cu deﬁciency included leucopenia and
neutropenia. In these subjects, Cu deﬁciency is likely to result from
malabsorption consecutive to stomach and duodenum bypass [85].
Kelley et al. [86] have examined the effect of three levels of Cu intake
on several markers of immune function in 11 healthy humans suc-
cessively fed diets providing 0.66, 0.38 and 2.49 mg/day Cu. At the
end of the 0.38 mg  period, peripheral blood mononuclear cell pro-
liferation and secretion of the IL-2 receptor in the culture medium
were reduced. Neither parameter returned to baseline levels at the
end of the 24-day repletion period. In this study, the peripheral
blood number of leucocytes, monocytes, neutrophils, lymphocytes
or natural killer cells were unaffected by the diet.
More recently, Turnlund et al. [58] have investigated the effect
of increasing Cu intake from 1.6 (normal) to 7.8 (high) mg/day
on several immune-related parameters and humoral response
to inﬂuenza vaccination in healthy humans. However, because
inﬂuenza vaccination took place between the normal and high
Cu periods, the results of this study cannot be taken into account
because of its high risk of bias.
A signiﬁcant impact of Cu on the immune function can only
be observed in speciﬁc situations where Cu malabsorption may
be combined with low Cu intakes, such as post-bariatric surgery
patients.
In healthy subjects, marginal Cu intake such as observed in
the 5th percentile of dietary Cu in the French population (EAT) is
unlikely to result in modiﬁcations to immune parameters.
6. Conclusions
This review points out several gaps and unresolved issues which
make it difﬁcult to assess links between Cu intake and health and
Cu requirements.
First, although several putative biomarkers of Cu status includ-
ing plasma or serum Cu, ceruloplasmin, Cu/Zn SOD, diamine
oxidase or skin lysyl oxidase have been explored to date, none
of them have yet unequivocally proved to reﬂect changes in
Cu intake within the range observed in Western populations
(0.5–2.5 mg/day). Even though serum and plasma Cu were recently
proposed as markers of Cu status at the population level [47],
neither has been shown to vary for Cu intake ranging from 0.57
to 6 mg/day in well controlled studies, and plasma Cu barely
decreased when Cu intake fell well below the 5th percentile of
dietary Cu observed in Western populations. For other putative
biomarkers, either their speciﬁcity and sensitivity is too low or the
quality and number of studies examining their link with Cu intake
is insufﬁcient to support their use in the evaluation of Cu exposure.
At present, the lack of a suitable biomarker for Cu intake greatly
limits our capacity to assess the relationship between dietary Cu
exposure and health, and highlights the urgent need for high qual-
ity randomized controlled trials in healthy subjects evaluating the
responsiveness of putative new biomarkers of Cu status over a wide
Cu intake range.
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Second, although Cu intake is almost consistently assessed in
ost representative national dietary surveys and in many prospec-
ive studies, major uncertainties remain regarding the actual
istribution of total Cu intake within the population. Within the
ame city/region, considerable variations in the Cu concentration in
rinking water have been observed as a consequence of the nature
f household plumbing systems and water softness. The Cu con-
ent of vegetables has also been shown to vary depending on soil
omposition and agricultural practices. The use of national food
omposition databases with low Cu water concentration in cohort
tudies and national representative dietary surveys may  thus lead
o an underestimation of Cu exposure in a signiﬁcant number of
ndividuals, although the actual percentage is unknown.
Last, the number of large scale high quality studies examining
he relationship between Cu intake or putative biomarkers of Cu
tatus and health outcomes is very limited. The failure to observe
 relationship between Cu exposure or status and negative health
utcomes in most of these studies might suggest that Cu nutrition
s not an issue in Western countries and that for most people, Cu
ntake meets nutritional requirements. Alternatively (i) uncertain-
ies regarding Cu concentration in foods and water and (ii) the lack
f biomarkers of Cu status make it impossible to simply rule out
he risk of subject misclassiﬁcation in term of Cu exposure and may
onfuse the link between Cu intake and health.
It is clear regarding Cu and health that the absence of proof
s not proof of absence, but simply reﬂects the number of unre-
olved questions and uncertainties, and calls for studies with a more
omplete and precise evaluation of Cu exposure based on reliable
iomarkers of Cu status.
onﬂict of interest
The authors declare no conﬂict of interest.
cknowledgment
The present review is partially based on the data prepared
nder contract CT/EFSA/NUTRI/2012/04 (Literature search and
eview related to speciﬁc preparatory work in the establishment
f Dietary Reference Values for Cu) with the European Food Safety
uthority (EFSA). The full technical report provided is available
n EFSA’s website: http://www.efsa.europa.eu/en/supporting/pub/
02e.htm.
For the work carried out under this contract, ANSES received
9,000 euros from EFSA.
The opinions expressed in the present review are those of the
uthors and do not represent EFSA’s ofﬁcial position.
eferences
[1] M.  Bonham, J.M. O’Connor, B.M. Hannigan, J.J. Strain, The immune system as a
physiological indicator of marginal copper status? Br. J. Nutr. 87 (5) (2002)
393–403.
[2] J.Y. Uriu-Adams, C.L. Keen, Copper, oxidative stress, and human health, Mol.
Aspects Med. 26 (4–5) (2005) 268–298.
[3] R. Danzeisen, M.  Araya, B. Harrison, C. Keen, M.  Solioz, D. Thiele, et al., How
reliable and robust are current biomarkers for copper status? Br. J. Nutr. 98
(4) (2007) 676–683.
[4] L. Gambling, H.J. McArdle, Iron, copper and fetal development, Proc. Nutr. Soc.
63  (4) (2004) 553–562.
[5] M.K. Georgieff, Nutrition and the developing brain: nutrient priorities and
measurement, Am.  J. Clin. Nutr. 85 (2) (2007) 614S–620S.
[6] L.M. Klevay, L. Inman, L.K. Johnson, M.  Lawler, J.R. Mahalko, D.B. Milne, et al.,
Increased cholesterol in plasma in a young man  during experimental copper
depletion, Metab.: Clin. Exp. 33 (12) (1984) 1112–1118.
[7] S. Reiser, A. Powell, C.Y. Yang, J. Canary, Effect of copper intake on blood
cholesterol and its lipoprotein distribution in men, Nutr. Rep. Int. 36 (1987)
641–649.
[dicine and Biology 35 (2016) 107–115
[8] J.R. Turnlund, W.R. Keyes, S.K. Kim, Domek JM Long-term high copper intake:
effects on copper absorption, retention, and homeostasis in men, Am.  J. Clin.
Nutr. 81 (4) (2005) 822–828.
[9] H. Kodama, C. Fujisawa, W.  Bhadhprasit, Inherited copper transport
disorders: biochemical mechanisms, diagnosis, and treatment, Curr. Drug
Metab. 13 (3) (2012) 237–250.
10] J.R. Prohaska, Role of copper transporters in copper homeostasis, Am.  J. Clin.
Nutr. 88 (3) (2008) 826S–829S.
11] P.V. van den Berghe, L.W. Klomp, New developments in the regulation of
intestinal copper absorption, Nutr. Rev. 67 (11) (2009) 658–672.
12] L.J. Harvey, J.R. Dainty, W.J. Hollands, V.J. Bull, J.H. Beattie, T.I. Venelinov, et al.,
Use  of mathematical modeling to study copper metabolism in humans, Am.  J.
Clin. Nutr. 81 (4) (2005) 807–813.
13] L.J. Harvey, G. Majsak-Newman, J.R. Dainty, D.J. Lewis, N.J. Langford, H.M.
Crews, et al., Adaptive responses in men fed low- and high-copper diets, Br. J.
Nutr. 90 (1) (2003) 161–168.
14] L.J. Harvey, G. Majsak-Newman, J.R. Dainty, S.G. Wharf, M.D. Reid, J.H. Beattie,
et  al., Holmium as a faecal marker for copper absorption studies in adults,
Clin. Sci. (Lond.) 102 (2) (2002) 233–240.
15] P.E. Johnson, M.A. Stuart, J.R. Hunt, L. Mullen, T.L. Starks, 65Copper absorption
by  women fed intrinsically and extrinsically labeled goose meat, goose liver,
peanut butter and sunﬂower butter, J. Nutr. 118 (12) (1988) 1522–1528.
16] D.D. Milne, P.E. Johnson, L.M. Klevay, H.H. Sandstead, Effect of copper intake
on  balance, absorption, and status indices of copper in men, Nutr. Res. 10 (9)
(1990) 975–986.
17] J.R. Turnlund, Use of enriched stable isotopes to determine bioavailability of
trace elements in humans, Sci. Total Environ. 28 (1983) 385–392.
18] J.R. Turnlund, Copper nutriture, bioavailability, and the inﬂuence of dietary
factors, J. Am.  Diet. Assoc. 88 (3) (1988) 303–308.
19] J.R. Turnlund, W.R. Keyes, H.L. Anderson, L.L. Acord, Copper absorption and
retention in young men at three levels of dietary copper by use of the stable
isotope 65Cu, Am.  J. Clin. Nutr. 49 (5) (1989) 870–878.
20] J.R. Turnlund, W.R. Keyes, G.L. Peiffer, K.C. Scott, Copper absorption, excretion,
and retention by young men  consuming low dietary copper determined by
using the stable isotope 65Cu, Am.  J. Clin. Nutr. 67 (6) (1998) 1219–1225.
21] J.R. Turnlund, J.C. King, B. Gong, W.R. Keyes, M.C. Michel, A stable isotope
study of copper absorption in young men: effect of phytate and
alpha-cellulose, Am.  J. Clin. Nutr. 42 (1) (1985) 18–23.
22] J.R. Turnlund, M.C. Michel, W.R. Keyes, Y. Schutz, S. Margen, Copper
absorption in elderly men determined by using stable 65Cu, Am.  J. Clin. Nutr.
36 (4) (1982) 587–591.
23] P.E. Johnson, D.B. Milne, G.I. Lykken, Effects of age and sex on copper
absorption, biological half-life, and status in humans, Am.  J. Clin. Nutr. 56 (5)
(1992) 917–925.
24] M.  Olivares, B. Lonnerdal, S.A. Abrams, F. Pizarro, R. Uauy, Age and copper
intake do not affect copper absorption, measured with the use of 65Cu as a
tracer, in young infants, Am. J. Clin. Nutr. 76 (3) (2002) 641–645.
25] M.C. Linder, L. Wooten, P. Cerveza, S. Cotton, R. Shulze, N. Lomeli, Copper
transport, Am.  J. Clin. Nutr. 67 (5 Suppl) (1998) 965S–971S.
26] J.R. Turnlund, C.L. Keen, R.G. Smith, Copper status and urinary and salivary
copper in young men at three levels of dietary copper, Am. J. Clin. Nutr. 51 (4)
(1990) 658–664.
27] J.R. Turnlund, K.C. Scott, G.L. Peiffer, A.M. Jang, W.R. Keyes, C.L. Keen, et al.,
Copper status of young men  consuming a low-copper diet, Am. J. Clin. Nutr.
65  (1) (1997) 72–78.
28] M.  Greenough, L. Pase, I. Voskoboinik, M.J. Petris, A.W. O’Brien, J. Camakaris,
Signals regulating trafﬁcking of Menkes (MNK; ATP7A) copper-translocating
P-type ATPase in polarized MDCK cells, Am.  J. Physiol. Cell Physiol. 287 (5)
(2004) C1463–C1471.
29] R.A. Jacob, H.H. Sandstead, J.M. Munoz, L.M. Klevay, D.B. Milne, Whole body
surface loss of trace metals in normal males, Am.  J. Clin. Nutr. 34 (7) (1981)
1379–1383.
30] D.B. Milne, F.H. Nielsen, G.I. Lykken, Effect of dietary copper and sulfur amino
acids on copper homeostasis and selected indices of copper status in men,
Trace Elem. Man Anim. 7 (1991) 5–12.
31] J.R. Turnlund, Human whole-body copper metabolism, Am. J. Clin. Nutr. 67 (5
Suppl) (1998) 960S–964S.
32] V. Chaignon, I. Sanchez-Neira, P. Herrmann, B. Jaillard, P. Hinsinger, Copper
bioavailability and extractability as related to chemical properties of
contaminated soils from a vine-growing area, Environ. Pollut. 123 (2) (2003)
229–238.
33] R. Ginocchio, P.H. Rodriguez, R. Badilla-Ohlbaum, H.E. Allen, G.E. Lagos, Effect
of soil copper content and pH on copper uptake of selected vegetables grown
under controlled conditions, Environ. Toxicol. Chem./SETAC 21 (8) (2002)
1736–1744.
34] C.E. Marcato, E. Pinelli, M.  Cecchi, P. Winterton, M.  Guiresse, Bioavailability of
Cu  and Zn in raw and anaerobically digested pig slurry, Ecotoxicol. Environ.
Saf.  72 (5) (2009) 1538–1544.
35] S.S. Sadhra, A.D. Wheatley, H.J. Cross, Dietary exposure to copper in the
European Union and its assessment for EU regulatory risk assessment, Sci.
Total Environ. 374 (2–3) (2007) 223–234.36] B.P. Zietz, J.D. de Vergara, H. Dunkelberg, Copper concentrations in tap water
and  possible effects on infant’s health—results of a study in Lower Saxony,
Germany, Environ. Res. 92 (2) (2003) 129–138.
s in Me
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[85] E. Saltzman, J.P. Karl, Nutrient deﬁciencies after gastric bypass surgery, Annu.
Rev. Nutr. 33 (2013) 183–203.
[86] D.S. Kelley, P.A. Daudu, P.C. Taylor, B.E. Mackey, J.R. Turnlund, Effects of
low-copper diets on human immune response, Am. J. Clin. Nutr. 62 (2) (1995)
412–416.M. Bost et al. / Journal of Trace Element
37] R. Pettersson, F. Rasmussen, Daily intake of copper from drinking water
among young children in Sweden, Environ. Health Perspect. 107 (6) (1999)
441–446.
38] C. Bénetier, M.  Bertin, G. Calamassi-Tran, C. Dubuisson, A. Dufour, F. Gauchard,
et  al., Étude Individuelle Nationale des Consommations Alimentaires 2 (INCA
2) (2006–2007), Afssa, 2009, pp. 75–102.
39] B.R. Vinas, L.R. Barba, J. Ngo, M.  Gurinovic, R. Novakovic, A. Cavelaars, et al.,
Projected prevalence of inadequate nutrient intakes in Europe, Ann. Nutr.
Metab. 59 (2–4) (2012) 84–95.
40] US Department of Agriculture Ars. Total nutrient intakes: percent reporting
and  mean amounts of selected vitamins and minerals from food and dietary
supplements, by gender and age – What we  eat in America – NHANES,
2009–2010, 2012.
41] A. Flynn, T. Hirvonen, G.B. Mensink, M.C. Ocke, L. Serra-Majem, K. Stos, et al.,
Intake of selected nutrients from foods, from fortiﬁcation and from
supplements in various European countries, Food Nutr. Res. 53 (2009).
42] R.L. Bailey, V.L. Fulgoni 3rd, D.R. Keast, J.T. Dwyer, Dietary supplement use is
associated with higher intakes of minerals from food sources, Am. J. Clin.
Nutr. 94 (5) (2011) 1376–1381.
43] R.L. Bailey, V.L. Fulgoni III, D.R. Keast, C.V. Lentino, J.T. Dwyer, Do dietary
supplements improve micronutrient sufﬁciency in children and adolescents?
J.  Pediatr. 161 (5) (2012) 837–842.
44] M.  Abdulla, I. Andersson, N.G. Asp, K. Berthelsen, D. Birkhed, I. Dencker, et al.,
Nutrient intake and health status of vegans: chemical analyses of diets using
the duplicate portion sampling technique, Am.  J. Clin. Nutr. 34 (11) (1981)
2464–2477.
45] U.M. Donovan, R.S. Gibson, Dietary intakes of adolescent females consuming
vegetarian, semi-vegetarian, and omnivorous diets, J. Adolesc. Health 18 (4)
(1996) 292–300.
46] J.R. Hunt, R.A. Vanderpool, Apparent copper absorption from a vegetarian
diet, Am.  J. Clin. Nutr. 74 (6) (2001) 803–807.
47] L.J. Harvey, K. Ashton, L. Hooper, A. Casgrain, S.J. Fairweather-Tait, Methods of
assessment of copper status in humans: a systematic review, Am.  J. Clin. Nutr.
89 (6) (2009) 2009S–2024S.
48] L.J. Harvey, H.J. McArdle, Biomarkers of copper status: a brief update, Br. J.
Nutr. 99 (Suppl. 3) (2008) S10–S13.
49] A. Baker, L. Harvey, G. Majask-Newman, S. Fairweather-Tait, A. Flynn, K.
Cashman, Effect of dietary copper intakes on biochemical markers of bone
metabolism in healthy adult males, Eur. J. Clin. Nutr. 53 (5) (1999) 408–412.
50] C.D. Davis, Low dietary copper increases fecal free radical production, fecal
water alkaline phosphatase activity and cytotoxicity in healthy men, J. Nutr.
133 (2) (2003) 522–527.
51] D.B. Milne, F.H. Nielsen, Effects of a diet low in copper on copper-status
indicators in postmenopausal women, Am.  J. Clin. Nutr. 63 (3) (1996)
358–364.
52] R.B. Middleton, M.C. Linder, Synthesis and turnover of ceruloplasmin in rats
treated with 17 beta-estradiol, Arch. Biochem. Biophys. 302 (2) (1993)
362–368.
53] M.J. Werman, S.J. Bhathena, J.R. Turnlund, Dietary copper intake inﬂuences
skin lysyl oxidase in young men, J. Nutr. Biochem. 8 (4) (1997) 201–204.
54] M.  Araya, M.  Olivares, F. Pizarro, M. Gonzalez, H. Speisky, R. Uauy,
Gastrointestinal symptoms and blood indicators of copper load in apparently
healthy adults undergoing controlled copper exposure, Am.  J. Clin. Nutr. 77
(3)  (2003) 646–650.
55] C.A. Kehoe, E. Turley, M.P. Bonham, J.M. O’Connor, A. McKeown, M.S.
Faughnan, et al., Response of putative indices of copper status to copper
supplementation in human subjects, Br. J. Nutr. 84 (2) (2000) 151–156.
56] D.B. Milne, C.D. Davis, F.H. Nielsen, Low dietary zinc alters indices of copper
function and status in postmenopausal women, Nutrition 17 (9) (2001)
701–708.
57] E. Turley, A. McKeown, M.P. Bonham, J.M. O’Connor, M.  Chopra, L.J. Harvey,
et  al., Copper supplementation in humans does not affect the susceptibility of
low density lipoprotein to in vitro induced oxidation (FOODCUE project), Free
Radic. Biol. Med. 29 (11) (2000) 1129–1134.
58] J.R. Turnlund, R.A. Jacob, C.L. Keen, J.J. Strain, D.S. Kelley, J.M. Domek, et al.,
Long-term high copper intake: effects on indexes of copper status,
antioxidant status, and immune function in young men, Am.  J. Clin. Nutr. 79
(6)  (2004) 1037–1044.
59] J.M. O’Connor, M.P. Bonham, E. Turley, A. McKeown, V.J. McKelvey-Martin,
W.S. Gilmore, et al., Copper supplementation has no effect on markers of DNA
damage and liver function in healthy adults (FOODCUE project), Ann. Nutr.
Metab. 47 (5) (2003) 201–206.
60] A. Khalique, S. Ahmad, T. Anjum, M.  Jaffar, M.H. Shah, N. Shaheen, et al., A
comparative study based on gender and age dependence of selected metals in
scalp hair, Environ. Monit. Assess. 104 (1–3) (2005) 45–57.
61] I. Rodushkin, M.D. Axelsson, Application of double focusing sector ﬁeld
ICP-MS for multielemental characterization of human hair and nails: Part II. A
study of the inhabitants of northern Sweden, Sci. Total Environ. 262 (1–2)
(2000) 21–36.dicine and Biology 35 (2016) 107–115 115
62] J. Suliburska, A comparison of levels of select minerals in scalp hair samples
with estimated dietary intakes of these minerals in women  of reproductive
age, Biol. Trace Elem. Res. 144 (1–3) (2011) 77–85.
63] I.M. Kempson, W.M.  Skinner, K.P. Kirkbride, The occurrence and incorporation
of  copper and zinc in hair and their potential role as bioindicators: a review, J.
Toxicol. Environ. Health B Crit. Rev. 10 (8) (2007) 611–622.
64] W.T. Buckley, R.A. Vanderpool, Analytical variables affecting exchangeable
copper determination in blood plasma, Biometals 21 (6) (2008) 601–612.
65] N. Gletsu-Miller, M.  Broderius, J.K. Frediani, V.M. Zhao, D.P. Grifﬁth, S.S. Davis
Jr.,  et al., Incidence and prevalence of copper deﬁciency following roux-en-y
gastric bypass surgery, Int. J. Obes. (Lond.) 36 (3) (2012) 328–335.
66] S.R. Jaiser, G.P. Winston, Copper deﬁciency myelopathy, J. Neurol. 257 (6)
(2010) 869–881.
67] M.M.  Singh, R. Singh, A. Khare, M.C. Gupta, N.L. Patney, V.K. Jain, et al., Serum
copper in myocardial infarction–diagnostic and prognostic signiﬁcance,
Angiology 36 (8) (1985) 504–510.
68] F.J. Kok, C.M. Van Duijn, A. Hofman, G.B. Van der Voet, F.A. De Wolff, C.H.
Paays, et al., Serum copper and zinc and the risk of death from cancer and
cardiovascular disease, Am. J. Epidemiol. 128 (2) (1988) 352–359.
69] J.T. Salonen, R. Salonen, H. Korpela, S. Suntioinen, J. Tuomilehto, Serum copper
and the risk of acute myocardial infarction: a prospective population study in
men  in eastern Finland, Am.  J. Epidemiol. 134 (3) (1991) 268–276.
70] C.J. Bates, M.  Hamer, G.D. Mishra, Redox-modulatory vitamins and minerals
that prospectively predict mortality in older British people: the national diet
and nutrition survey of people aged 65 years and over, Br. J. Nutr. 105 (1)
(2011) 123–132.
71] S. Bo, M.  Durazzo, R. Gambino, C. Berutti, N. Milanesio, A. Caropreso, et al.,
Associations of dietary and serum copper with inﬂammation, oxidative stress,
and metabolic variables in adults, J. Nutr. 138 (2) (2008) 305–310.
72] M.  Ghayour-Mobarhan, A. Taylor, S.A. New, D.J. Lamb, G.A. Ferns,
Determinants of serum copper, zinc and selenium in healthy subjects, Ann.
Clin.  Biochem. 42 (Pt. 5) (2005) 364–375.
73] D.M. Medeiros, A. Milton, E. Brunett, L. Stacy, Copper supplementation effects
on  indicators of copper status and serum cholesterol in adult males, Biol.
Trace Elem. Res. 30 (1) (1991) 19–35.
74] P. Zatta, D. Drago, P. Zambenedetti, S. Bolognin, E. Nogara, A. Peruffo, et al.,
Accumulation of copper and other metal ions, and metallothionein I/II
expression in the bovine brain as a function of aging, J. Chem. Neuroanat. 36
(1) (2008) 1–5.
75] P.K. Lam, D. Kritz-Silverstein, E. Barrett Connor, D. Milne, F. Nielsen, A. Gamst,
et  al., Plasma trace elements and cognitive function in older men and women:
the Rancho Bernardo study, J. Nutr. Health Aging 12 (1) (2008) 22–27.
76] C. Salustri, G. Barbati, R. Ghidoni, L. Quintiliani, S. Ciappina, G. Binetti, et al., Is
cognitive function linked to serum free copper levels? A cohort study in a
normal population, Clin. Neurophysiol. 121 (4) (2010) 502–507.
77] G.J. Brewer, Copper toxicity in Alzheimer’s disease: cognitive loss from
ingestion of inorganic copper, J. Trace Elem. Med. Biol. 26 (2–3) (2012) 89–92.
78] L.M. Klevay, Copper and cognition, Clin. Neurophysiol. 121 (12) (2010) 2177.
79] M.C. Morris, D.A. Evans, C.C. Tangney, J.L. Bienias, J.A. Schneider, R.S. Wilson,
et  al., Dietary copper and high saturated and trans fat intakes associated with
cognitive decline, Arch. Neurol. 63 (8) (2006) 1085–1088.
80] S. Mahabir, M.R. Forman, Y.Q. Dong, Y. Park, A. Hollenbeck, A. Schatzkin,
Mineral intake and lung cancer risk in the NIH-American Association of
Retired Persons Diet and Health study, Cancer Epidemiol. Biomarkers Prev. 19
(8)  (2010) 1976–1983.
81] C.A. Thompson, T.M. Habermann, A.H. Wang, R.A. Vierkant, A.R. Folsom, J.A.
Ross, et al., Antioxidant intake from fruits, vegetables and other sources and
risk of non-Hodgkin’s lymphoma: the Iowa Women’s Health Study, Int. J.
Cancer 126 (4) (2010) 992–1003.
82] F. Cavallo, M.  Gerber, E. Marubini, S. Richardson, A. Barbieri, A. Costa, et al.,
Zinc and copper in breast cancer: a joint study in northern Italy and southern
France, Cancer 67 (3) (1991) 738–745.
83] J. Dabek, M. Hyvonen-Dabek, H. Adlercreutz, M.  Harkonen, E. Hamalainen, A.
Ollus, et al., Simultaneous investigation of dietary and plasma copper, zinc,
iron and selenium in pre- and post-menopausal omnivores, vegetarians and
patients with early breast cancer, J. Nutr. Med. 4 (4) (1994) 403–414.
84] J.R. Cerhan, K.G. Saag, L.A. Merlino, T.R. Mikuls, L.A. Criswell, Antioxidant
micronutrients and risk of rheumatoid arthritis in a cohort of older women,
Am.  J. Epidemiol. 157 (4) (2003) 345–354.
